APPLE INC., 10-Q filed on 1/30/2026
Quarterly Report
v3.25.4
Cover Page - shares
shares in Thousands
3 Months Ended
Dec. 27, 2025
Jan. 16, 2026
Entity Information [Line Items]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Dec. 27, 2025  
Document Transition Report false  
Entity File Number 001-36743  
Entity Registrant Name Apple Inc.  
Entity Incorporation, State or Country Code CA  
Entity Tax Identification Number 94-2404110  
Entity Address, Address Line One One Apple Park Way  
Entity Address, City or Town Cupertino  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 95014  
City Area Code 408  
Local Phone Number 996-1010  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding (in shares)   14,681,140
Amendment Flag false  
Document Fiscal Year Focus 2026  
Document Fiscal Period Focus Q1  
Entity Central Index Key 0000320193  
Current Fiscal Year End Date --09-26  
Common Stock, $0.00001 par value per share    
Entity Information [Line Items]    
Title of 12(b) Security Common Stock, $0.00001 par value per share  
Trading Symbol AAPL  
Security Exchange Name NASDAQ  
1.625% Notes due 2026    
Entity Information [Line Items]    
Title of 12(b) Security 1.625% Notes due 2026  
No Trading Symbol Flag true  
Security Exchange Name NASDAQ  
2.000% Notes due 2027    
Entity Information [Line Items]    
Title of 12(b) Security 2.000% Notes due 2027  
No Trading Symbol Flag true  
Security Exchange Name NASDAQ  
1.375% Notes due 2029    
Entity Information [Line Items]    
Title of 12(b) Security 1.375% Notes due 2029  
No Trading Symbol Flag true  
Security Exchange Name NASDAQ  
3.050% Notes due 2029    
Entity Information [Line Items]    
Title of 12(b) Security 3.050% Notes due 2029  
No Trading Symbol Flag true  
Security Exchange Name NASDAQ  
0.500% Notes due 2031    
Entity Information [Line Items]    
Title of 12(b) Security 0.500% Notes due 2031  
No Trading Symbol Flag true  
Security Exchange Name NASDAQ  
3.600% Notes due 2042    
Entity Information [Line Items]    
Title of 12(b) Security 3.600% Notes due 2042  
No Trading Symbol Flag true  
Security Exchange Name NASDAQ  
v3.25.4
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
shares in Thousands, $ in Millions
3 Months Ended
Dec. 27, 2025
Dec. 28, 2024
Net sales $ 143,756 $ 124,300
Cost of sales 74,525 66,025
Gross margin 69,231 58,275
Operating expenses:    
Research and development 10,887 8,268
Selling, general and administrative 7,492 7,175
Total operating expenses 18,379 15,443
Operating income 50,852 42,832
Other income/(expense), net 150 (248)
Income before provision for income taxes 51,002 42,584
Provision for income taxes 8,905 6,254
Net income $ 42,097 $ 36,330
Earnings per share:    
Basic (in dollars per share) $ 2.85 $ 2.41
Diluted (in dollars per share) $ 2.84 $ 2.40
Shares used in computing earnings per share:    
Basic (in shares) 14,748,158 15,081,724
Diluted (in shares) 14,810,356 15,150,865
Products    
Net sales $ 113,743 $ 97,960
Cost of sales 67,478 59,447
Services    
Net sales 30,013 26,340
Cost of sales $ 7,047 $ 6,578
v3.25.4
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited) - USD ($)
$ in Millions
3 Months Ended
Dec. 27, 2025
Dec. 28, 2024
Statement of Comprehensive Income [Abstract]    
Net income $ 42,097 $ 36,330
Other comprehensive income/(loss):    
Change in foreign currency translation, net of tax (159) (625)
Change in unrealized gains/losses on derivative instruments, net of tax:    
Change in fair value of derivative instruments 211 1,651
Adjustment for net (gains)/losses realized and included in net income 237 784
Total change in unrealized gains/losses on derivative instruments 448 2,435
Change in unrealized gains/losses on marketable debt securities, net of tax:    
Change in fair value of marketable debt securities 424 (1,647)
Adjustment for net (gains)/losses realized and included in net income 4 220
Total change in unrealized gains/losses on marketable debt securities 428 (1,427)
Other comprehensive income 717 383
Total comprehensive income $ 42,814 $ 36,713
v3.25.4
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)
$ in Millions
Dec. 27, 2025
Sep. 27, 2025
Current assets:    
Cash and cash equivalents $ 45,317 $ 35,934
Marketable securities 21,590 18,763
Accounts receivable, net 39,921 39,777
Vendor non-trade receivables 30,399 33,180
Inventories 5,875 5,718
Other current assets 15,002 14,585
Total current assets 158,104 147,957
Non-current assets:    
Marketable securities 77,888 77,723
Property, plant and equipment, net 50,159 49,834
Other non-current assets 93,146 83,727
Total non-current assets 221,193 211,284
Total assets 379,297 359,241
Current liabilities:    
Accounts payable 70,587 69,860
Other current liabilities 68,543 66,387
Deferred revenue 9,413 9,055
Commercial paper 1,997 7,979
Term debt 11,827 12,350
Total current liabilities 162,367 165,631
Non-current liabilities:    
Term debt 76,685 78,328
Other non-current liabilities 52,055 41,549
Total non-current liabilities 128,740 119,877
Total liabilities 291,107 285,508
Commitments and contingencies
Shareholders’ equity:    
Common stock and additional paid-in capital, $0.00001 par value: 50,400,000 shares authorized; 14,702,703 and 14,773,260 shares issued and outstanding, respectively 95,221 93,568
Accumulated deficit (2,177) (14,264)
Accumulated other comprehensive loss (4,854) (5,571)
Total shareholders’ equity 88,190 73,733
Total liabilities and shareholders’ equity $ 379,297 $ 359,241
v3.25.4
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - $ / shares
Dec. 27, 2025
Sep. 27, 2025
Statement of Financial Position [Abstract]    
Common stock, par value (in dollars per share) $ 0.00001 $ 0.00001
Common stock, shares authorized (in shares) 50,400,000,000 50,400,000,000
Common stock, shares issued (in shares) 14,702,703,000 14,773,260,000
Common stock, shares outstanding (in shares) 14,702,703,000 14,773,260,000
v3.25.4
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Unaudited) - USD ($)
$ in Millions
Total
Common stock and additional paid-in capital
Retained earnings/(Accumulated deficit)
Accumulated other comprehensive income/(loss)
Beginning balances at Sep. 28, 2024 $ 56,950 $ 83,276 $ (19,154) $ (7,172)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Common stock withheld related to net share settlement of equity awards   (1,891) (1,102)  
Share-based compensation   3,383    
Net income 36,330   36,330  
Dividends and dividend equivalents declared     (3,819)  
Common stock repurchased     (23,476)  
Other comprehensive income 383     383
Ending balances at Dec. 28, 2024 $ 66,758 84,768 (11,221) (6,789)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Dividends and dividend equivalents declared per share or RSU (in dollars per share or RSU) $ 0.25      
Beginning balances at Sep. 27, 2025 $ 73,733 93,568 (14,264) (5,571)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Common stock withheld related to net share settlement of equity awards   (2,058) (936)  
Share-based compensation   3,711    
Net income 42,097   42,097  
Dividends and dividend equivalents declared     (3,880)  
Common stock repurchased (25,000)   (25,194)  
Other comprehensive income 717     717
Ending balances at Dec. 27, 2025 $ 88,190 $ 95,221 $ (2,177) $ (4,854)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Dividends and dividend equivalents declared per share or RSU (in dollars per share or RSU) $ 0.26      
v3.25.4
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Millions
3 Months Ended
Dec. 27, 2025
Dec. 28, 2024
Statement of Cash Flows [Abstract]    
Cash, cash equivalents, and restricted cash and cash equivalents, beginning balances $ 35,934 $ 29,943
Operating activities:    
Net income 42,097 36,330
Adjustments to reconcile net income to cash generated by operating activities:    
Depreciation and amortization 3,214 3,080
Share-based compensation expense 3,594 3,286
Other (528) (2,009)
Changes in operating assets and liabilities:    
Accounts receivable, net (153) 3,597
Vendor non-trade receivables 2,781 3,166
Inventories (211) 215
Other current and non-current assets (10,250) 939
Accounts payable 848 (6,671)
Other current and non-current liabilities 12,533 (11,998)
Cash generated by operating activities 53,925 29,935
Investing activities:    
Purchases of marketable securities (12,693) (6,124)
Proceeds from maturities of marketable securities 7,510 15,967
Proceeds from sales of marketable securities 2,824 3,492
Payments for acquisition of property, plant and equipment (2,373) (2,940)
Other (154) (603)
Cash generated by/(used in) investing activities (4,886) 9,792
Financing activities:    
Payments for taxes related to net share settlement of equity awards (2,922) (2,921)
Payments for dividends and dividend equivalents (3,921) (3,856)
Repurchases of common stock (24,701) (23,606)
Repayments of term debt (2,164) (1,009)
Total repayments of commercial paper, net (5,910) (7,944)
Other (38) (35)
Cash used in financing activities (39,656) (39,371)
Increase in cash, cash equivalents, and restricted cash and cash equivalents 9,383 356
Cash, cash equivalents, and restricted cash and cash equivalents, ending balances 45,317 30,299
Supplemental cash flow disclosure:    
Cash paid for income taxes, net $ 3,434 $ 18,651
v3.25.4
Summary of Significant Accounting Policies
3 Months Ended
Dec. 27, 2025
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies Summary of Significant Accounting Policies
Basis of Presentation and Preparation
The condensed consolidated financial statements include the accounts of Apple Inc. and its wholly owned subsidiaries (collectively “Apple” or the “Company”). In the opinion of the Company’s management, the condensed consolidated financial statements reflect all adjustments, which are normal and recurring in nature, necessary for fair financial statement presentation. The preparation of these condensed consolidated financial statements and accompanying notes in conformity with U.S. generally accepted accounting principles (“GAAP”) requires the use of management estimates. These condensed consolidated financial statements and accompanying notes should be read in conjunction with the Company’s annual consolidated financial statements and accompanying notes included in its Annual Report on Form 10-K for the fiscal year ended September 27, 2025 (the “2025 Form 10-K”).
The Company’s fiscal year is the 52- or 53-week period that ends on the last Saturday of September. An additional week is included in the first fiscal quarter every five or six years to realign the Company’s fiscal quarters with calendar quarters. The Company’s fiscal years 2026 and 2025 span 52 weeks each. Unless otherwise stated, references to particular years, quarters, months and periods refer to the Company’s fiscal years ended in September and the associated quarters, months and periods of those fiscal years.
v3.25.4
Revenue
3 Months Ended
Dec. 27, 2025
Revenue from Contract with Customer [Abstract]  
Revenue Revenue
The following table shows disaggregated net sales, as well as the portion of total net sales that was previously deferred, for the three months ended December 27, 2025 and December 28, 2024 (in millions):
Three Months Ended
December 27,
2025
December 28,
2024
iPhone®
$85,269 $69,138 
Mac®
8,386 8,987 
iPad®
8,595 8,088 
Wearables, Home and Accessories11,493 11,747 
Services30,013 26,340 
Total net sales$143,756 $124,300 
Portion of total net sales that was included in deferred revenue as of the beginning of the period
$4,050 $3,690 
The Company’s proportion of net sales by disaggregated revenue source was generally consistent for each reportable segment in Note 10, “Segment Information” for the three months ended December 27, 2025 and December 28, 2024, except in Greater China, where iPhone revenue represented a moderately higher proportion of net sales.
As of December 27, 2025 and September 27, 2025, the Company had total deferred revenue of $14.3 billion and $13.7 billion, respectively. As of December 27, 2025, the Company expects 66% of total deferred revenue to be realized in less than a year, 23% within one-to-two years, 9% within two-to-three years and 2% in greater than three years.
v3.25.4
Earnings Per Share
3 Months Ended
Dec. 27, 2025
Earnings Per Share [Abstract]  
Earnings Per Share Earnings Per Share
The following table shows the computation of basic and diluted earnings per share for the three months ended December 27, 2025 and December 28, 2024 (net income in millions and shares in thousands):
Three Months Ended
December 27,
2025
December 28,
2024
Numerator:
Net income$42,097 $36,330 
Denominator:
Weighted-average basic shares outstanding14,748,158 15,081,724 
Effect of dilutive share-based awards
62,198 69,141 
Weighted-average diluted shares14,810,356 15,150,865 
Basic earnings per share$2.85 $2.41 
Diluted earnings per share$2.84 $2.40 
v3.25.4
Financial Instruments
3 Months Ended
Dec. 27, 2025
Financial Instruments [Abstract]  
Financial Instruments Financial Instruments
Cash, Cash Equivalents and Marketable Securities
The following tables show the Company’s cash, cash equivalents and marketable securities by significant investment category as of December 27, 2025 and September 27, 2025 (in millions):
December 27, 2025
Adjusted
Cost
Unrealized
Gains
Unrealized
Losses
Fair
Value
Cash and
Cash
Equivalents
Current
Marketable
Securities
Non-Current
Marketable
Securities
Cash$30,826 $— $— $30,826 $30,826 $— $— 
Level 1:
Money market funds5,959 — — 5,959 5,959 — — 
Mutual funds
792 195 (2)985 — 985 — 
Subtotal6,751 195 (2)6,944 5,959 985 — 
Level 2 (1):
U.S. Treasury securities18,715 64 (211)18,568 2,302 5,341 10,925 
U.S. agency securities8,692 (114)8,579 4,192 1,998 2,389 
Non-U.S. government securities6,675 117 (399)6,393 — 771 5,622 
Certificates of deposit and time deposits1,737 — — 1,737 1,723 — 14 
Commercial paper991 — — 991 297 694 — 
Corporate debt securities46,682 280 (695)46,267 18 11,568 34,681 
Municipal securities154 — (1)153 — 97 56 
Mortgage- and asset-backed securities25,296 158 (1,117)24,337 — 136 24,201 
Subtotal108,942 620 (2,537)107,025 8,532 20,605 77,888 
Total
$146,519 $815 $(2,539)$144,795 $45,317 $21,590 $77,888 
September 27, 2025
Adjusted
Cost
Unrealized
Gains
Unrealized
Losses
Fair
Value
Cash and
Cash
Equivalents
Current
Marketable
Securities
Non-Current
Marketable
Securities
Cash$28,267 $— $— $28,267 $28,267 $— $— 
Level 1:
Money market funds5,272 — — 5,272 5,272 — — 
Mutual funds
679 177 (2)854 — 854 — 
Subtotal5,951 177 (2)6,126 5,272 854 — 
Level 2 (1):
U.S. Treasury securities16,074 56 (282)15,848 1,190 3,712 10,946 
U.S. agency securities5,269 — (149)5,120 251 2,456 2,413 
Non-U.S. government securities6,586 111 (424)6,273 — 855 5,418 
Certificates of deposit and time deposits917 — — 917 904 — 13 
Commercial paper100 — — 100 50 50 — 
Corporate debt securities47,210 266 (916)46,560 — 10,623 35,937 
Municipal securities207 — (2)205 — 119 86 
Mortgage- and asset-backed securities24,130 126 (1,252)23,004 — 94 22,910 
Subtotal100,493 559 (3,025)98,027 2,395 17,909 77,723 
Total
$134,711 $736 $(3,027)$132,420 $35,934 $18,763 $77,723 
(1)The valuation techniques used to measure the fair values of the Company’s Level 2 financial instruments, which generally have counterparties with high credit ratings, are based on quoted market prices or model-driven valuations using significant inputs derived from or corroborated by observable market data.
As of December 27, 2025, 78% of the Company’s non-current marketable debt securities other than mortgage- and asset-backed securities had maturities between 1 and 5 years, 17% between 5 and 10 years, and 5% greater than 10 years. As of December 27, 2025, 12% of the Company’s non-current mortgage- and asset-backed securities had maturities between 1 and 5 years, 18% between 5 and 10 years, and 70% greater than 10 years.
Derivative Instruments and Hedging
The Company may use derivative instruments to partially offset its business exposure to foreign exchange and interest rate risk. However, the Company may choose not to hedge certain exposures for a variety of reasons, including accounting considerations or the prohibitive economic cost of hedging particular exposures. There can be no assurance the hedges will offset more than a portion of the financial impact resulting from movements in foreign exchange or interest rates.
Foreign Exchange Rate Risk
To protect gross margins from fluctuations in foreign exchange rates, the Company may use forwards, options or other instruments, and may designate these instruments as cash flow hedges. The Company generally hedges portions of its forecasted foreign currency exposure associated with revenue and inventory purchases, typically for up to 12 months.
To protect the Company’s foreign currency–denominated term debt or marketable securities from fluctuations in foreign exchange rates, the Company may use forwards, cross-currency swaps or other instruments. The Company designates these instruments as either cash flow or fair value hedges. As of December 27, 2025, the maximum length of time over which the Company is hedging its exposure to the variability in future cash flows for term debt–related foreign currency transactions is 17 years.
The Company may also use derivative instruments that are not designated as accounting hedges to protect gross margins from certain fluctuations in foreign exchange rates, as well as to offset a portion of the foreign currency gains and losses generated by the remeasurement of certain assets and liabilities denominated in non-functional currencies.
Interest Rate Risk
To protect the Company’s term debt or marketable securities from fluctuations in interest rates, the Company may use interest rate swaps, options or other instruments. The Company designates these instruments as either cash flow or fair value hedges.
The notional amounts of the Company’s outstanding derivative instruments as of December 27, 2025 and September 27, 2025, were as follows (in millions):
December 27,
2025
September 27,
2025
Derivative instruments designated as accounting hedges:
Foreign exchange contracts$46,619 $62,647 
Interest rate contracts$12,875 $12,875 
Derivative instruments not designated as accounting hedges:
Foreign exchange contracts$120,980 $109,079 
As of both December 27, 2025 and September 27, 2025, the carrying amount of the Company’s current and non-current term debt subject to fair value hedges was $12.6 billion.
Accounts Receivable
Trade Receivables
As of December 27, 2025, the Company had two customers that individually represented 10% or more of total trade receivables, which accounted for 15% and 10%. As of September 27, 2025, the Company had one customer that represented 10% or more of total trade receivables, which accounted for 12%. The Company’s third-party cellular network carriers accounted for 35% and 34% of total trade receivables as of December 27, 2025 and September 27, 2025, respectively. The Company requires third-party credit support or collateral from certain customers to limit credit risk.
Vendor Non-Trade Receivables
The Company has non-trade receivables from certain of its manufacturing vendors resulting from the sale of components to these vendors who manufacture subassemblies or assemble final products for the Company. The Company purchases these components directly from suppliers. The Company does not reflect the sale of these components in products net sales. Rather, the Company recognizes any gain on these sales as a reduction of products cost of sales when the related final products are sold by the Company. As of December 27, 2025, the Company had two vendors that individually represented 10% or more of total vendor non-trade receivables, which accounted for 47% and 26%. As of September 27, 2025, the Company had two vendors that individually represented 10% or more of total vendor non-trade receivables, which accounted for 46% and 23%.
v3.25.4
Condensed Consolidated Financial Statement Details
3 Months Ended
Dec. 27, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Condensed Consolidated Financial Statement Details Condensed Consolidated Financial Statement Details
The following table shows the Company’s condensed consolidated financial statement details as of December 27, 2025 and September 27, 2025 (in millions):
Property, Plant and Equipment, Net
December 27,
2025
September 27,
2025
Gross property, plant and equipment$127,320 $125,848 
Accumulated depreciation
(77,161)(76,014)
Total property, plant and equipment, net$50,159 $49,834 
v3.25.4
Debt
3 Months Ended
Dec. 27, 2025
Debt Disclosure [Abstract]  
Debt Debt
Commercial Paper
The Company issues unsecured short-term promissory notes pursuant to a commercial paper program. The Company uses net proceeds from the commercial paper program for general corporate purposes, including dividends and share repurchases. As of December 27, 2025 and September 27, 2025, the Company had $2.0 billion and $8.0 billion of commercial paper outstanding, respectively. The following table provides a summary of cash flows associated with commercial paper for the three months ended December 27, 2025 and December 28, 2024 (in millions):
Three Months Ended
December 27,
2025
December 28,
2024
Maturities 90 days or less:
Repayments of commercial paper, net$(2,122)$(7,944)
Maturities greater than 90 days:
Repayments of commercial paper(3,788)— 
Total repayments of commercial paper, net$(5,910)$(7,944)
Term Debt
As of December 27, 2025 and September 27, 2025, the Company had outstanding fixed-rate notes with varying maturities for an aggregate carrying amount of $88.5 billion and $90.7 billion, respectively (collectively the “Notes”). As of December 27, 2025 and September 27, 2025, the fair value of the Company’s Notes, based on Level 2 inputs, was $78.1 billion and $80.4 billion, respectively.
v3.25.4
Shareholders' Equity
3 Months Ended
Dec. 27, 2025
Equity [Abstract]  
Shareholders' Equity Shareholders’ Equity
Share Repurchase Program
During the three months ended December 27, 2025, the Company repurchased 93 million shares of its common stock for $25.0 billion. The Company’s share repurchase program does not obligate the Company to acquire a minimum amount of shares. Under the program, shares may be repurchased in privately negotiated or open market transactions, including under plans complying with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended (“Exchange Act”).
v3.25.4
Share-Based Compensation
3 Months Ended
Dec. 27, 2025
Share-Based Payment Arrangement [Abstract]  
Share-Based Compensation Share-Based Compensation
Restricted Stock Units
A summary of the Company’s restricted stock unit (“RSU”) activity and related information for the three months ended December 27, 2025, is as follows:
Number of
RSUs
(in thousands)
Weighted-Average
Grant-Date Fair
Value Per RSU
Balance as of September 27, 2025151,574 $189.75 
RSUs granted61,897 $256.22 
RSUs vested(33,905)$173.00 
RSUs forfeited(3,470)$208.14 
Balance as of December 27, 2025176,096 $215.98 
The total vesting-date fair value of RSUs was $8.6 billion and $8.4 billion for the three months ended December 27, 2025 and December 28, 2024, respectively.
Share-Based Compensation
The following table shows share-based compensation expense and the related income tax benefit included in the Condensed Consolidated Statements of Operations for the three months ended December 27, 2025 and December 28, 2024 (in millions):
Three Months Ended
December 27,
2025
December 28,
2024
Share-based compensation expense$3,594 $3,286 
Income tax benefit related to share-based compensation expense$(1,293)$(1,332)
As of December 27, 2025, the total unrecognized compensation cost related to outstanding RSUs was $31.5 billion, which the Company expects to recognize over a weighted-average period of 2.9 years.
v3.25.4
Commitments and Contingencies
3 Months Ended
Dec. 27, 2025
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and Contingencies
Unconditional Purchase Obligations
The Company has entered into certain off–balance sheet commitments that require the future purchase of goods or services (“unconditional purchase obligations”). The Company’s unconditional purchase obligations primarily consist of supplier arrangements, licensed intellectual property and content, and distribution rights. Future payments under unconditional purchase obligations with a remaining term in excess of one year as of December 27, 2025, are as follows (in millions):
2026 (remaining nine months)
$4,754 
20278,066 
20287,005 
20296,538 
20305,992 
Thereafter827 
Total$33,182 
Contingencies
The Company is subject to various legal proceedings and claims that have arisen in the ordinary course of business and that have not been fully resolved. The outcome of litigation is inherently uncertain. In the opinion of management, there was not at least a reasonable possibility the Company may have incurred a material loss, or a material loss greater than a recorded accrual, concerning loss contingencies for asserted legal and other claims.
v3.25.4
Segment Information
3 Months Ended
Dec. 27, 2025
Segment Reporting [Abstract]  
Segment Information Segment Information
The following table shows information by reportable segment for the three months ended December 27, 2025 and December 28, 2024 (in millions):
Three Months Ended December 27, 2025
AmericasEurope
Greater
China
JapanRest of
Asia Pacific
CorporateTotal
Net sales$58,529 $38,146 $25,526 $9,413 $12,142 $— $143,756 
Cost of sales(31,849)(19,061)(13,030)(4,511)(6,074)— (74,525)
Research and development— — — — — (10,887)(10,887)
Selling and marketing(2,727)(1,295)(704)(289)(382)— (5,397)
General and administrative— — — — — (2,095)(2,095)
Operating income/(loss)$23,953 $17,790 $11,792 $4,613 $5,686 $(12,982)$50,852 
Three Months Ended December 28, 2024
AmericasEuropeGreater
China
JapanRest of
Asia Pacific
CorporateTotal
Net sales$52,648 $33,861 $18,513 $8,987 $10,291 $— $124,300 
Cost of sales(28,495)(18,043)(9,759)(4,393)(5,335)— (66,025)
Research and development— — — — — (8,268)(8,268)
Selling and marketing(2,644)(1,211)(594)(280)(372)— (5,101)
General and administrative— — — — — (2,074)(2,074)
Operating income/(loss)$21,509 $14,607 $8,160 $4,314 $4,584 $(10,342)$42,832 
v3.25.4
Insider Trading Arrangements
3 Months Ended
Dec. 27, 2025
Trading Arrangements, by Individual  
Non-Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Terminated false
Kevan Parekh [Member]  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
On November 21, 2025, Kevan Parekh, the Company’s Senior Vice President and Chief Financial Officer, entered into a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act. The plan provides for the sale, subject to certain price limits, of shares vesting between April 15, 2026 and October 15, 2026, pursuant to certain equity awards granted to Mr. Parekh, excluding any shares withheld by the Company to satisfy income tax withholding and remittance obligations. Mr. Parekh’s plan will expire on December 31, 2026, subject to early termination in accordance with the terms of the plan.
Name Kevan Parekh
Title Senior Vice President and Chief Financial Officer
Rule 10b5-1 Arrangement Adopted true
Adoption Date November 21, 2025
Expiration Date December 31, 2026
Arrangement Duration 406 days
Deirdre O'Brien [Member]  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
On November 24, 2025, Deirdre O’Brien, the Company’s Senior Vice President, Retail + People, terminated a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act, which was previously adopted on August 27, 2024 (the “Prior Plan”). The Prior Plan provided for the sale, subject to certain price limits, of shares vesting between April 1, 2025 and October 1, 2026, pursuant to certain equity awards granted to Ms. O’Brien, excluding any shares withheld by the Company to satisfy income tax withholding and remittance obligations. The Prior Plan would have expired on December 31, 2026, subject to early termination in accordance with the terms of the plan. Following termination of the Prior Plan, on November 24, 2025, Ms. O’Brien entered into a new trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act. The new plan provides for the sale of shares vesting between April 1, 2026 and October 1, 2026, pursuant to certain equity awards granted to Ms. O’Brien, excluding any shares withheld by the Company to satisfy income tax withholding and remittance obligations. Ms. O’Brien’s new plan will expire on December 31, 2026, subject to early termination in accordance with the terms of the plan.
Name Deirdre O’Brien
Title Company’s Senior Vice President, Retail + People
Rule 10b5-1 Arrangement Adopted true
Adoption Date November 24, 2025
Rule 10b5-1 Arrangement Terminated true
Termination Date November 24, 2025
Expiration Date December 31, 2026
Arrangement Duration 403 days
v3.25.4
Summary of Significant Accounting Policies (Policies)
3 Months Ended
Dec. 27, 2025
Accounting Policies [Abstract]  
Basis of Presentation and Preparation
Basis of Presentation and Preparation
The condensed consolidated financial statements include the accounts of Apple Inc. and its wholly owned subsidiaries (collectively “Apple” or the “Company”). In the opinion of the Company’s management, the condensed consolidated financial statements reflect all adjustments, which are normal and recurring in nature, necessary for fair financial statement presentation. The preparation of these condensed consolidated financial statements and accompanying notes in conformity with U.S. generally accepted accounting principles (“GAAP”) requires the use of management estimates. These condensed consolidated financial statements and accompanying notes should be read in conjunction with the Company’s annual consolidated financial statements and accompanying notes included in its Annual Report on Form 10-K for the fiscal year ended September 27, 2025 (the “2025 Form 10-K”).
Fiscal Period
The Company’s fiscal year is the 52- or 53-week period that ends on the last Saturday of September. An additional week is included in the first fiscal quarter every five or six years to realign the Company’s fiscal quarters with calendar quarters. The Company’s fiscal years 2026 and 2025 span 52 weeks each. Unless otherwise stated, references to particular years, quarters, months and periods refer to the Company’s fiscal years ended in September and the associated quarters, months and periods of those fiscal years.
Fair Value Measurements The valuation techniques used to measure the fair values of the Company’s Level 2 financial instruments, which generally have counterparties with high credit ratings, are based on quoted market prices or model-driven valuations using significant inputs derived from or corroborated by observable market data.
v3.25.4
Revenue (Tables)
3 Months Ended
Dec. 27, 2025
Revenue from Contract with Customer [Abstract]  
Disaggregated Net Sales and Portion of Net Sales That Was Previously Deferred
The following table shows disaggregated net sales, as well as the portion of total net sales that was previously deferred, for the three months ended December 27, 2025 and December 28, 2024 (in millions):
Three Months Ended
December 27,
2025
December 28,
2024
iPhone®
$85,269 $69,138 
Mac®
8,386 8,987 
iPad®
8,595 8,088 
Wearables, Home and Accessories11,493 11,747 
Services30,013 26,340 
Total net sales$143,756 $124,300 
Portion of total net sales that was included in deferred revenue as of the beginning of the period
$4,050 $3,690 
v3.25.4
Earnings Per Share (Tables)
3 Months Ended
Dec. 27, 2025
Earnings Per Share [Abstract]  
Computation of Basic and Diluted Earnings Per Share
The following table shows the computation of basic and diluted earnings per share for the three months ended December 27, 2025 and December 28, 2024 (net income in millions and shares in thousands):
Three Months Ended
December 27,
2025
December 28,
2024
Numerator:
Net income$42,097 $36,330 
Denominator:
Weighted-average basic shares outstanding14,748,158 15,081,724 
Effect of dilutive share-based awards
62,198 69,141 
Weighted-average diluted shares14,810,356 15,150,865 
Basic earnings per share$2.85 $2.41 
Diluted earnings per share$2.84 $2.40 
v3.25.4
Financial Instruments (Tables)
3 Months Ended
Dec. 27, 2025
Financial Instruments [Abstract]  
Cash, Cash Equivalents and Marketable Securities by Significant Investment Category
The following tables show the Company’s cash, cash equivalents and marketable securities by significant investment category as of December 27, 2025 and September 27, 2025 (in millions):
December 27, 2025
Adjusted
Cost
Unrealized
Gains
Unrealized
Losses
Fair
Value
Cash and
Cash
Equivalents
Current
Marketable
Securities
Non-Current
Marketable
Securities
Cash$30,826 $— $— $30,826 $30,826 $— $— 
Level 1:
Money market funds5,959 — — 5,959 5,959 — — 
Mutual funds
792 195 (2)985 — 985 — 
Subtotal6,751 195 (2)6,944 5,959 985 — 
Level 2 (1):
U.S. Treasury securities18,715 64 (211)18,568 2,302 5,341 10,925 
U.S. agency securities8,692 (114)8,579 4,192 1,998 2,389 
Non-U.S. government securities6,675 117 (399)6,393 — 771 5,622 
Certificates of deposit and time deposits1,737 — — 1,737 1,723 — 14 
Commercial paper991 — — 991 297 694 — 
Corporate debt securities46,682 280 (695)46,267 18 11,568 34,681 
Municipal securities154 — (1)153 — 97 56 
Mortgage- and asset-backed securities25,296 158 (1,117)24,337 — 136 24,201 
Subtotal108,942 620 (2,537)107,025 8,532 20,605 77,888 
Total
$146,519 $815 $(2,539)$144,795 $45,317 $21,590 $77,888 
September 27, 2025
Adjusted
Cost
Unrealized
Gains
Unrealized
Losses
Fair
Value
Cash and
Cash
Equivalents
Current
Marketable
Securities
Non-Current
Marketable
Securities
Cash$28,267 $— $— $28,267 $28,267 $— $— 
Level 1:
Money market funds5,272 — — 5,272 5,272 — — 
Mutual funds
679 177 (2)854 — 854 — 
Subtotal5,951 177 (2)6,126 5,272 854 — 
Level 2 (1):
U.S. Treasury securities16,074 56 (282)15,848 1,190 3,712 10,946 
U.S. agency securities5,269 — (149)5,120 251 2,456 2,413 
Non-U.S. government securities6,586 111 (424)6,273 — 855 5,418 
Certificates of deposit and time deposits917 — — 917 904 — 13 
Commercial paper100 — — 100 50 50 — 
Corporate debt securities47,210 266 (916)46,560 — 10,623 35,937 
Municipal securities207 — (2)205 — 119 86 
Mortgage- and asset-backed securities24,130 126 (1,252)23,004 — 94 22,910 
Subtotal100,493 559 (3,025)98,027 2,395 17,909 77,723 
Total
$134,711 $736 $(3,027)$132,420 $35,934 $18,763 $77,723 
(1)The valuation techniques used to measure the fair values of the Company’s Level 2 financial instruments, which generally have counterparties with high credit ratings, are based on quoted market prices or model-driven valuations using significant inputs derived from or corroborated by observable market data.
Notional Amounts of Outstanding Derivative Instruments
The notional amounts of the Company’s outstanding derivative instruments as of December 27, 2025 and September 27, 2025, were as follows (in millions):
December 27,
2025
September 27,
2025
Derivative instruments designated as accounting hedges:
Foreign exchange contracts$46,619 $62,647 
Interest rate contracts$12,875 $12,875 
Derivative instruments not designated as accounting hedges:
Foreign exchange contracts$120,980 $109,079 
v3.25.4
Condensed Consolidated Financial Statement Details (Tables)
3 Months Ended
Dec. 27, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Property, Plant and Equipment, Net
Property, Plant and Equipment, Net
December 27,
2025
September 27,
2025
Gross property, plant and equipment$127,320 $125,848 
Accumulated depreciation
(77,161)(76,014)
Total property, plant and equipment, net$50,159 $49,834 
v3.25.4
Debt (Tables)
3 Months Ended
Dec. 27, 2025
Debt Disclosure [Abstract]  
Summary of Cash Flows Associated with Commercial Paper The following table provides a summary of cash flows associated with commercial paper for the three months ended December 27, 2025 and December 28, 2024 (in millions):
Three Months Ended
December 27,
2025
December 28,
2024
Maturities 90 days or less:
Repayments of commercial paper, net$(2,122)$(7,944)
Maturities greater than 90 days:
Repayments of commercial paper(3,788)— 
Total repayments of commercial paper, net$(5,910)$(7,944)
v3.25.4
Share-Based Compensation (Tables)
3 Months Ended
Dec. 27, 2025
Share-Based Payment Arrangement [Abstract]  
Restricted Stock Unit Activity
A summary of the Company’s restricted stock unit (“RSU”) activity and related information for the three months ended December 27, 2025, is as follows:
Number of
RSUs
(in thousands)
Weighted-Average
Grant-Date Fair
Value Per RSU
Balance as of September 27, 2025151,574 $189.75 
RSUs granted61,897 $256.22 
RSUs vested(33,905)$173.00 
RSUs forfeited(3,470)$208.14 
Balance as of December 27, 2025176,096 $215.98 
Share-Based Compensation Expense and the Related Income Tax Benefit
The following table shows share-based compensation expense and the related income tax benefit included in the Condensed Consolidated Statements of Operations for the three months ended December 27, 2025 and December 28, 2024 (in millions):
Three Months Ended
December 27,
2025
December 28,
2024
Share-based compensation expense$3,594 $3,286 
Income tax benefit related to share-based compensation expense$(1,293)$(1,332)
v3.25.4
Commitments and Contingencies (Tables)
3 Months Ended
Dec. 27, 2025
Commitments and Contingencies Disclosure [Abstract]  
Future Payments Under Unconditional Purchase Obligations Future payments under unconditional purchase obligations with a remaining term in excess of one year as of December 27, 2025, are as follows (in millions):
2026 (remaining nine months)
$4,754 
20278,066 
20287,005 
20296,538 
20305,992 
Thereafter827 
Total$33,182 
v3.25.4
Segment Information (Tables)
3 Months Ended
Dec. 27, 2025
Segment Reporting [Abstract]  
Information by Reportable Segment
The following table shows information by reportable segment for the three months ended December 27, 2025 and December 28, 2024 (in millions):
Three Months Ended December 27, 2025
AmericasEurope
Greater
China
JapanRest of
Asia Pacific
CorporateTotal
Net sales$58,529 $38,146 $25,526 $9,413 $12,142 $— $143,756 
Cost of sales(31,849)(19,061)(13,030)(4,511)(6,074)— (74,525)
Research and development— — — — — (10,887)(10,887)
Selling and marketing(2,727)(1,295)(704)(289)(382)— (5,397)
General and administrative— — — — — (2,095)(2,095)
Operating income/(loss)$23,953 $17,790 $11,792 $4,613 $5,686 $(12,982)$50,852 
Three Months Ended December 28, 2024
AmericasEuropeGreater
China
JapanRest of
Asia Pacific
CorporateTotal
Net sales$52,648 $33,861 $18,513 $8,987 $10,291 $— $124,300 
Cost of sales(28,495)(18,043)(9,759)(4,393)(5,335)— (66,025)
Research and development— — — — — (8,268)(8,268)
Selling and marketing(2,644)(1,211)(594)(280)(372)— (5,101)
General and administrative— — — — — (2,074)(2,074)
Operating income/(loss)$21,509 $14,607 $8,160 $4,314 $4,584 $(10,342)$42,832 
v3.25.4
Revenue - Disaggregated Net Sales and Portion of Net Sales That Was Previously Deferred (Details) - USD ($)
$ in Millions
3 Months Ended
Dec. 27, 2025
Dec. 28, 2024
Disaggregation of Revenue [Line Items]    
Net sales $ 143,756 $ 124,300
Portion of total net sales that was included in deferred revenue as of the beginning of the period 4,050 3,690
iPhone    
Disaggregation of Revenue [Line Items]    
Net sales 85,269 69,138
Mac    
Disaggregation of Revenue [Line Items]    
Net sales 8,386 8,987
iPad    
Disaggregation of Revenue [Line Items]    
Net sales 8,595 8,088
Wearables, Home and Accessories    
Disaggregation of Revenue [Line Items]    
Net sales 11,493 11,747
Services    
Disaggregation of Revenue [Line Items]    
Net sales $ 30,013 $ 26,340
v3.25.4
Revenue - Additional Information (Details) - USD ($)
$ in Billions
Dec. 27, 2025
Sep. 27, 2025
Revenue from Contract with Customer [Abstract]    
Total deferred revenue $ 14.3 $ 13.7
v3.25.4
Revenue - Deferred Revenue, Expected Timing of Realization (Details)
Dec. 27, 2025
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-12-28  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Deferred revenue, expected timing of realization, percentage 66.00%
Deferred revenue, expected timing of realization, period 1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-12-27  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Deferred revenue, expected timing of realization, percentage 23.00%
Deferred revenue, expected timing of realization, period 1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2028-01-02  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Deferred revenue, expected timing of realization, percentage 9.00%
Deferred revenue, expected timing of realization, period 1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2028-12-31  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Deferred revenue, expected timing of realization, percentage 2.00%
Deferred revenue, expected timing of realization, period 1 year
v3.25.4
Earnings Per Share - Computation of Basic and Diluted Earnings Per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Millions
3 Months Ended
Dec. 27, 2025
Dec. 28, 2024
Numerator:    
Net income $ 42,097 $ 36,330
Denominator:    
Weighted-average basic shares outstanding (in shares) 14,748,158 15,081,724
Effect of dilutive share-based awards (in shares) 62,198 69,141
Weighted-average diluted shares (in shares) 14,810,356 15,150,865
Basic earnings per share (in dollars per share) $ 2.85 $ 2.41
Diluted earnings per share (in dollars per share) $ 2.84 $ 2.40
v3.25.4
Financial Instruments - Cash, Cash Equivalents and Marketable Securities (Details) - USD ($)
$ in Millions
Dec. 27, 2025
Sep. 27, 2025
Marketable Securities [Line Items]    
Cash, Cash Equivalents and Marketable Securities, Adjusted Cost $ 146,519 $ 134,711
Cash Equivalents and Marketable Securities, Unrealized Gains 815 736
Cash Equivalents and Marketable Securities, Unrealized Losses (2,539) (3,027)
Cash, Cash Equivalents and Marketable Securities, Fair Value 144,795 132,420
Cash and Cash Equivalents 45,317 35,934
Current Marketable Securities 21,590 18,763
Non-Current
Marketable
Securities 77,888 77,723
Level 1    
Marketable Securities [Line Items]    
Marketable Securities, Equity, Adjusted Cost 6,751 5,951
Marketable Securities, Equity, Unrealized Gains 195 177
Marketable Securities, Equity, Unrealized Losses (2) (2)
Marketable Securities, Equity, Fair Value 6,944 6,126
Cash and Cash Equivalents 5,959 5,272
Current Marketable Securities 985 854
Non-Current
Marketable
Securities 0 0
Level 2    
Marketable Securities [Line Items]    
Marketable Securities, Debt, Adjusted Cost 108,942 100,493
Marketable Securities, Debt, Unrealized Gains 620 559
Marketable Securities, Debt, Unrealized Losses (2,537) (3,025)
Marketable Securities, Debt, Fair Value 107,025 98,027
Cash and Cash Equivalents 8,532 2,395
Current Marketable Securities 20,605 17,909
Non-Current
Marketable
Securities 77,888 77,723
Cash    
Marketable Securities [Line Items]    
Cash 30,826 28,267
Cash and Cash Equivalents 30,826 28,267
Money market funds | Level 1    
Marketable Securities [Line Items]    
Marketable Securities, Equity, Adjusted Cost 5,959 5,272
Marketable Securities, Equity, Unrealized Gains 0 0
Marketable Securities, Equity, Unrealized Losses 0 0
Marketable Securities, Equity, Fair Value 5,959 5,272
Cash and Cash Equivalents 5,959 5,272
Current Marketable Securities 0 0
Non-Current
Marketable
Securities 0 0
Mutual funds | Level 1    
Marketable Securities [Line Items]    
Marketable Securities, Equity, Adjusted Cost 792 679
Marketable Securities, Equity, Unrealized Gains 195 177
Marketable Securities, Equity, Unrealized Losses (2) (2)
Marketable Securities, Equity, Fair Value 985 854
Cash and Cash Equivalents 0 0
Current Marketable Securities 985 854
Non-Current
Marketable
Securities 0 0
U.S. Treasury securities | Level 2    
Marketable Securities [Line Items]    
Marketable Securities, Debt, Adjusted Cost 18,715 16,074
Marketable Securities, Debt, Unrealized Gains 64 56
Marketable Securities, Debt, Unrealized Losses (211) (282)
Marketable Securities, Debt, Fair Value 18,568 15,848
Cash and Cash Equivalents 2,302 1,190
Current Marketable Securities 5,341 3,712
Non-Current
Marketable
Securities 10,925 10,946
U.S. agency securities | Level 2    
Marketable Securities [Line Items]    
Marketable Securities, Debt, Adjusted Cost 8,692 5,269
Marketable Securities, Debt, Unrealized Gains 1 0
Marketable Securities, Debt, Unrealized Losses (114) (149)
Marketable Securities, Debt, Fair Value 8,579 5,120
Cash and Cash Equivalents 4,192 251
Current Marketable Securities 1,998 2,456
Non-Current
Marketable
Securities 2,389 2,413
Non-U.S. government securities | Level 2    
Marketable Securities [Line Items]    
Marketable Securities, Debt, Adjusted Cost 6,675 6,586
Marketable Securities, Debt, Unrealized Gains 117 111
Marketable Securities, Debt, Unrealized Losses (399) (424)
Marketable Securities, Debt, Fair Value 6,393 6,273
Cash and Cash Equivalents 0 0
Current Marketable Securities 771 855
Non-Current
Marketable
Securities 5,622 5,418
Certificates of deposit and time deposits | Level 2    
Marketable Securities [Line Items]    
Marketable Securities, Debt, Adjusted Cost 1,737 917
Marketable Securities, Debt, Unrealized Gains 0 0
Marketable Securities, Debt, Unrealized Losses 0 0
Marketable Securities, Debt, Fair Value 1,737 917
Cash and Cash Equivalents 1,723 904
Current Marketable Securities 0 0
Non-Current
Marketable
Securities 14 13
Commercial paper | Level 2    
Marketable Securities [Line Items]    
Marketable Securities, Debt, Adjusted Cost 991 100
Marketable Securities, Debt, Unrealized Gains 0 0
Marketable Securities, Debt, Unrealized Losses 0 0
Marketable Securities, Debt, Fair Value 991 100
Cash and Cash Equivalents 297 50
Current Marketable Securities 694 50
Non-Current
Marketable
Securities 0 0
Corporate debt securities | Level 2    
Marketable Securities [Line Items]    
Marketable Securities, Debt, Adjusted Cost 46,682 47,210
Marketable Securities, Debt, Unrealized Gains 280 266
Marketable Securities, Debt, Unrealized Losses (695) (916)
Marketable Securities, Debt, Fair Value 46,267 46,560
Cash and Cash Equivalents 18 0
Current Marketable Securities 11,568 10,623
Non-Current
Marketable
Securities 34,681 35,937
Municipal securities | Level 2    
Marketable Securities [Line Items]    
Marketable Securities, Debt, Adjusted Cost 154 207
Marketable Securities, Debt, Unrealized Gains 0 0
Marketable Securities, Debt, Unrealized Losses (1) (2)
Marketable Securities, Debt, Fair Value 153 205
Cash and Cash Equivalents 0 0
Current Marketable Securities 97 119
Non-Current
Marketable
Securities 56 86
Mortgage- and asset-backed securities | Level 2    
Marketable Securities [Line Items]    
Marketable Securities, Debt, Adjusted Cost 25,296 24,130
Marketable Securities, Debt, Unrealized Gains 158 126
Marketable Securities, Debt, Unrealized Losses (1,117) (1,252)
Marketable Securities, Debt, Fair Value 24,337 23,004
Cash and Cash Equivalents 0 0
Current Marketable Securities 136 94
Non-Current
Marketable
Securities $ 24,201 $ 22,910
v3.25.4
Financial Instruments - Additional Information (Details)
$ in Billions
3 Months Ended 12 Months Ended
Dec. 27, 2025
USD ($)
Vendor
Customer
Sep. 27, 2025
USD ($)
Customer
Vendor
Debt Securities, Available-for-Sale, Maturity, Fair Value, Rolling Maturity [Abstract]    
Carrying amount of hedged term debt | $ $ 12.6 $ 12.6
Hedged liability, statement of financial position [Extensible Enumeration] Term debt Term debt
Trade receivables | Credit concentration risk    
Debt Securities, Available-for-Sale, Maturity, Fair Value, Rolling Maturity [Abstract]    
Number of customers that individually represented 10% or more of total trade receivables | Customer 2 1
Trade receivables | Credit concentration risk | Customer one    
Debt Securities, Available-for-Sale, Maturity, Fair Value, Rolling Maturity [Abstract]    
Concentration risk, percentage 15.00% 12.00%
Trade receivables | Credit concentration risk | Customer two    
Debt Securities, Available-for-Sale, Maturity, Fair Value, Rolling Maturity [Abstract]    
Concentration risk, percentage 10.00%  
Trade receivables | Credit concentration risk | Cellular network carriers    
Debt Securities, Available-for-Sale, Maturity, Fair Value, Rolling Maturity [Abstract]    
Concentration risk, percentage 35.00% 34.00%
Non-trade receivables | Credit concentration risk    
Debt Securities, Available-for-Sale, Maturity, Fair Value, Rolling Maturity [Abstract]    
Number of vendors that individually represented 10% or more of total vendor non-trade receivables | Vendor 2 2
Non-trade receivables | Credit concentration risk | Vendor one    
Debt Securities, Available-for-Sale, Maturity, Fair Value, Rolling Maturity [Abstract]    
Concentration risk, percentage 47.00% 46.00%
Non-trade receivables | Credit concentration risk | Vendor two    
Debt Securities, Available-for-Sale, Maturity, Fair Value, Rolling Maturity [Abstract]    
Concentration risk, percentage 26.00% 23.00%
Hedges of foreign currency exposure associated with revenue and inventory purchases    
Debt Securities, Available-for-Sale, Maturity, Fair Value, Rolling Maturity [Abstract]    
Maximum length of time over which the Company is hedging its exposure to the variability in future cash flows for foreign currency transactions 12 months  
Hedges of foreign currency exposure associated with term debt    
Debt Securities, Available-for-Sale, Maturity, Fair Value, Rolling Maturity [Abstract]    
Maximum length of time over which the Company is hedging its exposure to the variability in future cash flows for foreign currency transactions 17 years  
Marketable debt securities other than mortgage- and asset-backed securities    
Debt Securities, Available-for-Sale, Maturity, Fair Value, Rolling Maturity [Abstract]    
Between 1 and 5 years 78.00%  
Between 5 and 10 years 17.00%  
Greater than 10 years 5.00%  
Mortgage- and asset-backed securities    
Debt Securities, Available-for-Sale, Maturity, Fair Value, Rolling Maturity [Abstract]    
Between 1 and 5 years 12.00%  
Between 5 and 10 years 18.00%  
Greater than 10 years 70.00%  
v3.25.4
Financial Instruments - Notional Amounts of Derivative Instruments (Details) - USD ($)
$ in Millions
Dec. 27, 2025
Sep. 27, 2025
Derivatives designated as accounting hedges | Foreign exchange contracts    
Derivatives, Fair Value [Line Items]    
Derivatives, notional amount $ 46,619 $ 62,647
Derivatives designated as accounting hedges | Interest rate contracts    
Derivatives, Fair Value [Line Items]    
Derivatives, notional amount 12,875 12,875
Derivatives not designated as accounting hedges | Foreign exchange contracts    
Derivatives, Fair Value [Line Items]    
Derivatives, notional amount $ 120,980 $ 109,079
v3.25.4
Condensed Consolidated Financial Statement Details - Property, Plant and Equipment, Net (Details) - USD ($)
$ in Millions
Dec. 27, 2025
Sep. 27, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Gross property, plant and equipment $ 127,320 $ 125,848
Accumulated depreciation (77,161) (76,014)
Total property, plant and equipment, net $ 50,159 $ 49,834
v3.25.4
Debt - Additional Information (Details) - USD ($)
$ in Millions
Dec. 27, 2025
Sep. 27, 2025
Debt Instrument [Line Items]    
Commercial paper $ 1,997 $ 7,979
Fixed-rate notes, aggregate carrying amount 88,500 90,700
Commercial paper    
Debt Instrument [Line Items]    
Commercial paper 2,000 8,000
Level 2    
Debt Instrument [Line Items]    
Fixed-rate notes, aggregate fair value $ 78,100 $ 80,400
v3.25.4
Debt - Summary of Cash Flows Associated with Commercial Paper (Details) - USD ($)
$ in Millions
3 Months Ended
Dec. 27, 2025
Dec. 28, 2024
Maturities 90 days or less:    
Repayments of commercial paper, net $ (2,122) $ (7,944)
Maturities greater than 90 days:    
Repayments of commercial paper (3,788) 0
Total repayments of commercial paper, net $ (5,910) $ (7,944)
v3.25.4
Shareholders' Equity - Additional Information (Details)
shares in Millions, $ in Billions
3 Months Ended
Dec. 27, 2025
USD ($)
shares
Stockholders' Equity Note [Abstract]  
Number of shares repurchased (in shares) | shares 93
Amount of share repurchases | $ $ 25.0
v3.25.4
Share-Based Compensation - Restricted Stock Unit Activity and Related Information (Details) - Restricted stock units
shares in Thousands
3 Months Ended
Dec. 27, 2025
$ / shares
shares
Number of Restricted Stock Units  
Beginning balance (in shares) | shares 151,574
RSUs granted (in shares) | shares 61,897
RSUs vested (in shares) | shares (33,905)
RSUs forfeited (in shares) | shares (3,470)
Ending balance (in shares) | shares 176,096
Weighted-Average Grant-Date Fair Value Per RSU  
Beginning balance (in dollars per share) | $ / shares $ 189.75
RSUs granted (in dollars per share) | $ / shares 256.22
RSUs vested (in dollars per share) | $ / shares 173.00
RSUs forfeited (in dollars per share) | $ / shares 208.14
Ending balance (in dollars per share) | $ / shares $ 215.98
v3.25.4
Share-Based Compensation - Additional Information (Details) - Restricted stock units - USD ($)
$ in Billions
3 Months Ended
Dec. 27, 2025
Dec. 28, 2024
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Total vesting-date fair value of RSUs $ 8.6 $ 8.4
Total unrecognized compensation cost related to outstanding RSUs $ 31.5  
Total unrecognized compensation cost related to outstanding RSUs, weighted-average recognition period 2 years 10 months 24 days  
v3.25.4
Share-Based Compensation - Summary of Share-Based Compensation Expense and the Related Income Tax Benefit (Details) - USD ($)
$ in Millions
3 Months Ended
Dec. 27, 2025
Dec. 28, 2024
Share-Based Payment Arrangement [Abstract]    
Share-based compensation expense $ 3,594 $ 3,286
Income tax benefit related to share-based compensation expense $ (1,293) $ (1,332)
v3.25.4
Commitments and Contingencies - Future Payments Under Unconditional Purchase Obligations (Details)
$ in Millions
Dec. 27, 2025
USD ($)
Unconditional Purchase Obligation, Fiscal Year Maturity [Abstract]  
2026 (remaining nine months) $ 4,754
2027 8,066
2028 7,005
2029 6,538
2030 5,992
Thereafter 827
Total $ 33,182
v3.25.4
Segment Information - Additional Information (Details)
3 Months Ended
Dec. 27, 2025
Segment Reporting [Abstract]  
Number of reportable segments not disclosed flag true
v3.25.4
Segment Information - Information by Reportable Segment (Details) - USD ($)
$ in Millions
3 Months Ended
Dec. 27, 2025
Dec. 28, 2024
Segment Reporting Information [Line Items]    
Net sales $ 143,756 $ 124,300
Cost of sales (74,525) (66,025)
Research and development (10,887) (8,268)
Selling and marketing (5,397) (5,101)
General and administrative (2,095) (2,074)
Operating income 50,852 42,832
Corporate non-segment    
Segment Reporting Information [Line Items]    
Research and development (10,887) (8,268)
General and administrative (2,095) (2,074)
Operating income (12,982) (10,342)
Americas | Operating segments    
Segment Reporting Information [Line Items]    
Net sales 58,529 52,648
Cost of sales (31,849) (28,495)
Selling and marketing (2,727) (2,644)
Operating income 23,953 21,509
Europe | Operating segments    
Segment Reporting Information [Line Items]    
Net sales 38,146 33,861
Cost of sales (19,061) (18,043)
Selling and marketing (1,295) (1,211)
Operating income 17,790 14,607
Greater China | Operating segments    
Segment Reporting Information [Line Items]    
Net sales 25,526 18,513
Cost of sales (13,030) (9,759)
Selling and marketing (704) (594)
Operating income 11,792 8,160
Japan | Operating segments    
Segment Reporting Information [Line Items]    
Net sales 9,413 8,987
Cost of sales (4,511) (4,393)
Selling and marketing (289) (280)
Operating income 4,613 4,314
Rest of Asia Pacific | Operating segments    
Segment Reporting Information [Line Items]    
Net sales 12,142 10,291
Cost of sales (6,074) (5,335)
Selling and marketing (382) (372)
Operating income $ 5,686 $ 4,584